| - SMTL ID
- 5sju.1
- Ligands
- ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-{(4S)-4-[(piperidin-1-yl)methyl]-4,5-dihydro-1,3-thiazol-2-yl}-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sju.2
- Ligands
- ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-{(4S)-4-[(piperidin-1-yl)methyl]-4,5-dihydro-1,3-thiazol-2-yl}-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sju.3
- Ligands
- ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-{(4S)-4-[(piperidin-1-yl)methyl]-4,5-dihydro-1,3-thiazol-2-yl}-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sju.4
- Ligands
- ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-{(4S)-4-[(piperidin-1-yl)methyl]-4,5-dihydro-1,3-thiazol-2-yl}-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|